Department of Defense Awards ANP a Large Contract to Develop Nano-Antibody Cocktail to Treat Ebola Infection
Newark, DE (November 15, 2016) - On August 15, 2016, after a highly competitive bidding process, the Defense Threat Reduction Agency (DTRA) of the Department of Defense (DoD) awarded ANP Technologies, Inc. (ANP) a large contract to carry out the development of a new, highly effective, and temperature stable nano-antibody cocktail for the treatment of Ebola infection. As documented thoroughly in the news and other media formats, the recent outbreak in West Africa has devastated local communities as well as infected many of the clinicians and support groups tasked with mitigating the outbreak. Since 2013 when the most recent outbreak began, more than 11,000 people have succumbed to the deadly virus, highlighting Ebola’s extreme mortality rate.
Utilizing its innovative, platform Nano-drug delivery technology, ANP and its partners will develop a new Nano-antibody cocktail that boasts not only 100% protection from the vicious virus, but also endowed with superior temperature stability; a critical issue that has severely hindered efforts in the West Africa region to effectively treat the infected. With its proprietary nanotechnology and expert know-how, ANP has demonstrated that the new drug can withstand temperatures up to 70 °C. Because the West Africa region suffers from poor infrastructure and the lack of cold-chains, this innovative Ebola therapy provides the best solution to rapidly treat the current and future outbreaks without the need for expensive logistics and cold-chain storage conditions.
Dr. Ray Yin, ANP’s Chief Executive Officer commented, “This award has allowed us to further expand our nano-drug delivery technology from small molecule based therapeutics to large proteins and antibodies; an important market that ANP is trying to capture.”
About ANP Technologies, Inc.
ANP Technologies, Inc. is a world leader in developing and commercializing various Nano-biotechnology-based products for applications in Nano-therapeutics, immunogenicity testing, chemical and biological defense, medical diagnostics, as well as food safety testing.